Cargando…

Hepatic PKA inhibition accelerates the lipid accumulation in liver

BACKGROUND/AIMS: Liver lipid accumulation induced by high-fat diet (HFD) is an early onset process of non-alcoholic fatty liver diseases (NAFLD). Protein kinase A (PKA) is known to be involved in hepatic lipid metabolism. However, the role of PKA in NAFLD has not been well tested in vivo due to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jining, Zhang, Xiaoying, Yi, Long, Yang, Ling, Wang, Wei Eric, Zeng, Chunyu, Mi, Mantian, Chen, Xiongwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788098/
https://www.ncbi.nlm.nih.gov/pubmed/31632452
http://dx.doi.org/10.1186/s12986-019-0400-5
_version_ 1783458425458393088
author Yang, Jining
Zhang, Xiaoying
Yi, Long
Yang, Ling
Wang, Wei Eric
Zeng, Chunyu
Mi, Mantian
Chen, Xiongwen
author_facet Yang, Jining
Zhang, Xiaoying
Yi, Long
Yang, Ling
Wang, Wei Eric
Zeng, Chunyu
Mi, Mantian
Chen, Xiongwen
author_sort Yang, Jining
collection PubMed
description BACKGROUND/AIMS: Liver lipid accumulation induced by high-fat diet (HFD) is an early onset process of non-alcoholic fatty liver diseases (NAFLD). Protein kinase A (PKA) is known to be involved in hepatic lipid metabolism. However, the role of PKA in NAFLD has not been well tested in vivo due to the lack of optimal PKA deficient mouse model. METHODS: A novel PKA-specific inhibitor gene was conditionally overexpressed in mouse (PKAi mouse) liver using LoxP/Cre system. PKA activity in the liver extract was measured with a commercial assay kit. The PKAi and control mice of 8-week age, were subjected to HFD or chow diet (CD) for 2 months. Body weight, liver index, and triglyceride in the liver were measured. RNA sequencing was performed for the liver tissues and analyzed with Gene Ontology (GO) and pathway enrichment. RESULTS: PKAi-GFP protein was overexpressed in the liver and the PKA activation was significantly inhibited in the liver of PKAi mouse. When fed with CD, RNA sequencing revealed 56 up-regulated and 51 down-regulated genes in PKAi mice compared with control mice, which were mainly involved in lipid metabolism though no significant differences in the body weight, liver index, triglyceride accumulation were observed between PKAi and control mice. However, when fed with HFD for 2 months, the liver was enlarged more, and the accumulation of triglyceride in the liver was more severe in PKAi mice. When comparing the transcriptomes of CD-fed and HFD-fed control mice, GO enrichment showed that the genes down-regulated by HFD were mainly enriched in immune-related GO terms, and up-regulated genes were enriched in metabolism. When comparing the transcriptomes of CD-fed and HFD-fed PKAi mice, GO analysis showed that the down-regulated genes were enriched in metabolism, while the up-regulated genes were clustered in ER stress-related pathways. When comparing HFD-fed PKAi and HFD-fed control mice, the genes with lower expression level in PKAi mice were enriched in the lipoprotein synthesis, which might explain that more TG is accumulated in PKAi liver after HFD feeding. CONCLUSIONS: Reduced PKA activity could be a factor promoting the TG accumulation in the liver and the development of NAFLD.
format Online
Article
Text
id pubmed-6788098
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67880982019-10-18 Hepatic PKA inhibition accelerates the lipid accumulation in liver Yang, Jining Zhang, Xiaoying Yi, Long Yang, Ling Wang, Wei Eric Zeng, Chunyu Mi, Mantian Chen, Xiongwen Nutr Metab (Lond) Research BACKGROUND/AIMS: Liver lipid accumulation induced by high-fat diet (HFD) is an early onset process of non-alcoholic fatty liver diseases (NAFLD). Protein kinase A (PKA) is known to be involved in hepatic lipid metabolism. However, the role of PKA in NAFLD has not been well tested in vivo due to the lack of optimal PKA deficient mouse model. METHODS: A novel PKA-specific inhibitor gene was conditionally overexpressed in mouse (PKAi mouse) liver using LoxP/Cre system. PKA activity in the liver extract was measured with a commercial assay kit. The PKAi and control mice of 8-week age, were subjected to HFD or chow diet (CD) for 2 months. Body weight, liver index, and triglyceride in the liver were measured. RNA sequencing was performed for the liver tissues and analyzed with Gene Ontology (GO) and pathway enrichment. RESULTS: PKAi-GFP protein was overexpressed in the liver and the PKA activation was significantly inhibited in the liver of PKAi mouse. When fed with CD, RNA sequencing revealed 56 up-regulated and 51 down-regulated genes in PKAi mice compared with control mice, which were mainly involved in lipid metabolism though no significant differences in the body weight, liver index, triglyceride accumulation were observed between PKAi and control mice. However, when fed with HFD for 2 months, the liver was enlarged more, and the accumulation of triglyceride in the liver was more severe in PKAi mice. When comparing the transcriptomes of CD-fed and HFD-fed control mice, GO enrichment showed that the genes down-regulated by HFD were mainly enriched in immune-related GO terms, and up-regulated genes were enriched in metabolism. When comparing the transcriptomes of CD-fed and HFD-fed PKAi mice, GO analysis showed that the down-regulated genes were enriched in metabolism, while the up-regulated genes were clustered in ER stress-related pathways. When comparing HFD-fed PKAi and HFD-fed control mice, the genes with lower expression level in PKAi mice were enriched in the lipoprotein synthesis, which might explain that more TG is accumulated in PKAi liver after HFD feeding. CONCLUSIONS: Reduced PKA activity could be a factor promoting the TG accumulation in the liver and the development of NAFLD. BioMed Central 2019-10-11 /pmc/articles/PMC6788098/ /pubmed/31632452 http://dx.doi.org/10.1186/s12986-019-0400-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Yang, Jining
Zhang, Xiaoying
Yi, Long
Yang, Ling
Wang, Wei Eric
Zeng, Chunyu
Mi, Mantian
Chen, Xiongwen
Hepatic PKA inhibition accelerates the lipid accumulation in liver
title Hepatic PKA inhibition accelerates the lipid accumulation in liver
title_full Hepatic PKA inhibition accelerates the lipid accumulation in liver
title_fullStr Hepatic PKA inhibition accelerates the lipid accumulation in liver
title_full_unstemmed Hepatic PKA inhibition accelerates the lipid accumulation in liver
title_short Hepatic PKA inhibition accelerates the lipid accumulation in liver
title_sort hepatic pka inhibition accelerates the lipid accumulation in liver
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788098/
https://www.ncbi.nlm.nih.gov/pubmed/31632452
http://dx.doi.org/10.1186/s12986-019-0400-5
work_keys_str_mv AT yangjining hepaticpkainhibitionacceleratesthelipidaccumulationinliver
AT zhangxiaoying hepaticpkainhibitionacceleratesthelipidaccumulationinliver
AT yilong hepaticpkainhibitionacceleratesthelipidaccumulationinliver
AT yangling hepaticpkainhibitionacceleratesthelipidaccumulationinliver
AT wangweieric hepaticpkainhibitionacceleratesthelipidaccumulationinliver
AT zengchunyu hepaticpkainhibitionacceleratesthelipidaccumulationinliver
AT mimantian hepaticpkainhibitionacceleratesthelipidaccumulationinliver
AT chenxiongwen hepaticpkainhibitionacceleratesthelipidaccumulationinliver